These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 11727199)

  • 1. C-->U editing of neurofibromatosis 1 mRNA occurs in tumors that express both the type II transcript and apobec-1, the catalytic subunit of the apolipoprotein B mRNA-editing enzyme.
    Mukhopadhyay D; Anant S; Lee RM; Kennedy S; Viskochil D; Davidson NO
    Am J Hum Genet; 2002 Jan; 70(1):38-50. PubMed ID: 11727199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An AU-rich sequence element (UUUN[A/U]U) downstream of the edited C in apolipoprotein B mRNA is a high-affinity binding site for Apobec-1: binding of Apobec-1 to this motif in the 3' untranslated region of c-myc increases mRNA stability.
    Anant S; Davidson NO
    Mol Cell Biol; 2000 Mar; 20(6):1982-92. PubMed ID: 10688645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel role for RNA-binding protein CUGBP2 in mammalian RNA editing. CUGBP2 modulates C to U editing of apolipoprotein B mRNA by interacting with apobec-1 and ACF, the apobec-1 complementation factor.
    Anant S; Henderson JO; Mukhopadhyay D; Navaratnam N; Kennedy S; Min J; Davidson NO
    J Biol Chem; 2001 Dec; 276(50):47338-51. PubMed ID: 11577082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of GRY-RBP as an apolipoprotein B RNA-binding protein that interacts with both apobec-1 and apobec-1 complementation factor to modulate C to U editing.
    Blanc V; Navaratnam N; Henderson JO; Anant S; Kennedy S; Jarmuz A; Scott J; Davidson NO
    J Biol Chem; 2001 Mar; 276(13):10272-83. PubMed ID: 11134005
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The neurofibromatosis type I messenger RNA undergoes base-modification RNA editing.
    Skuse GR; Cappione AJ; Sowden M; Metheny LJ; Smith HC
    Nucleic Acids Res; 1996 Feb; 24(3):478-85. PubMed ID: 8602361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of domains in apobec-1 complementation factor required for RNA binding and apolipoprotein-B mRNA editing.
    Mehta A; Driscoll DM
    RNA; 2002 Jan; 8(1):69-82. PubMed ID: 11871661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of novel alternative splice variants of APOBEC-1 complementation factor with different capacities to support apolipoprotein B mRNA editing.
    Sowden MP; Lehmann DM; Lin X; Smith CO; Smith HC
    J Biol Chem; 2004 Jan; 279(1):197-206. PubMed ID: 14570923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutagenesis of apobec-1, the catalytic subunit of the mammalian apolipoprotein B mRNA editing enzyme, reveals distinct domains that mediate cytosine nucleoside deaminase, RNA binding, and RNA editing activity.
    MacGinnitie AJ; Anant S; Davidson NO
    J Biol Chem; 1995 Jun; 270(24):14768-75. PubMed ID: 7782343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ARCD-1, an apobec-1-related cytidine deaminase, exerts a dominant negative effect on C to U RNA editing.
    Anant S; Mukhopadhyay D; Sankaranand V; Kennedy S; Henderson JO; Davidson NO
    Am J Physiol Cell Physiol; 2001 Dec; 281(6):C1904-16. PubMed ID: 11698249
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determinants involved in regulating the proportion of edited apolipoprotein B RNAs.
    Sowden M; Hamm JK; Spinelli S; Smith HC
    RNA; 1996 Mar; 2(3):274-88. PubMed ID: 8608451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distinct promoters induce APOBEC-1 expression in rat liver and intestine.
    Greeve J; Axelos D; Welker S; Schipper M; Greten H
    Arterioscler Thromb Vasc Biol; 1998 Jul; 18(7):1079-92. PubMed ID: 9672068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of cytidine to uridine editing on cytoplasmic apolipoprotein B mRNA by overexpressing APOBEC-1.
    Yang Y; Sowden MP; Smith HC
    J Biol Chem; 2000 Jul; 275(30):22663-9. PubMed ID: 10833526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RNA editing: cytidine to uridine conversion in apolipoprotein B mRNA.
    Chester A; Scott J; Anant S; Navaratnam N
    Biochim Biophys Acta; 2000 Nov; 1494(1-2):1-13. PubMed ID: 11072063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reconstitution of mRNA editing in yeast using a Gal4-apoB-Gal80 fusion transcript as the selectable marker.
    Lellek H; Welker S; Diehl I; Kirsten R; Greeve J
    J Biol Chem; 2002 Jun; 277(26):23638-44. PubMed ID: 11976346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular cloning of apobec-1 complementation factor, a novel RNA-binding protein involved in the editing of apolipoprotein B mRNA.
    Mehta A; Kinter MT; Sherman NE; Driscoll DM
    Mol Cell Biol; 2000 Mar; 20(5):1846-54. PubMed ID: 10669759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cloning of an Apobec-1-binding protein that also interacts with apolipoprotein B mRNA and evidence for its involvement in RNA editing.
    Lau PP; Zhu HJ; Nakamuta M; Chan L
    J Biol Chem; 1997 Jan; 272(3):1452-5. PubMed ID: 8999813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene transfer of cytidine deaminase apoBEC-1 lowers lipoprotein(a) in transgenic mice and induces apolipoprotein B editing in rabbits.
    Hughes SD; Rouy D; Navaratnam N; Scott J; Rubin EM
    Hum Gene Ther; 1996 Jan; 7(1):39-49. PubMed ID: 8825867
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Secondary structure for the apolipoprotein B mRNA editing site. Au-binding proteins interact with a stem loop.
    Richardson N; Navaratnam N; Scott J
    J Biol Chem; 1998 Nov; 273(48):31707-17. PubMed ID: 9822632
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tissue-specific inhibition of apolipoprotein B mRNA editing in the liver by adenovirus-mediated transfer of a dominant negative mutant APOBEC-1 leads to increased low density lipoprotein in mice.
    Oka K; Kobayashi K; Sullivan M; Martinez J; Teng BB; Ishimura-Oka K; Chan L
    J Biol Chem; 1997 Jan; 272(3):1456-60. PubMed ID: 8999814
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disproportionate relationship between APOBEC-1 expression and apolipoprotein B mRNA editing activity.
    Siddiqui JF; Van Mater D; Sowden MP; Smith HC
    Exp Cell Res; 1999 Oct; 252(1):154-64. PubMed ID: 10502408
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.